Calithera Biosciences Stock Z Score
CALADelisted Stock | USD 0.05 0.00 0.00% |
Calithera |
Calithera Biosciences Company Z Score Analysis
Calithera Biosciences' Z-Score is a simple linear, multi-factor model that measures the financial health and economic stability of a company. The score is used to predict the probability of a firm going into bankruptcy within next 24 months or two fiscal years from the day stated on the accounting statements used to calculate it. The model uses five fundamental business ratios that are weighted according to algorithm of Professor Edward Altman who developed it in the late 1960s at New York University..
Current Calithera Biosciences Z Score | -29.14 |
Most of Calithera Biosciences' fundamental indicators, such as Z Score, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Calithera Biosciences is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
| |||||||
| |||||||
| |||||||
| |||||||
|
To calculate a Z-Score, one would need to know a company's current working capital, its total assets and liabilities, and the amount of its latest earnings as well as earnings before interest and tax. Z-Scores can be used to compare the odds of bankruptcy of companies in a similar line of business or firms operating in the same industry. Companies with Z-Scores above 3.1 are generally considered to be stable and healthy with a low probability of bankruptcy. Scores that fall between 1.8 and 3.1 lie in a so-called 'grey area,' with scores of less than 1 indicating the highest probability of distress. Z Score is a used widely measure by financial auditors, accountants, money managers, loan processors, wealth advisers, and day traders. In the last 25 years, many financial models that utilize z-scores proved it to be successful as a predictor of corporate bankruptcy.
CompetitionIn accordance with the company's disclosures, Calithera Biosciences has a Z Score of -29.14. This is 531.7% lower than that of the Biotechnology sector and notably lower than that of the Health Care industry. The z score for all United States stocks is notably higher than that of the company.
Did you try this?
Run Pair Correlation Now
Pair CorrelationCompare performance and examine fundamental relationship between any two equity instruments |
All Next | Launch Module |
Calithera Fundamentals
Return On Equity | -1.14 | ||||
Return On Asset | -0.56 | ||||
Current Valuation | (1.1 M) | ||||
Shares Outstanding | 4.87 M | ||||
Shares Owned By Insiders | 1.07 % | ||||
Shares Owned By Institutions | 26.76 % | ||||
Number Of Shares Shorted | 417.28 K | ||||
Price To Earning | (14.08) X | ||||
Price To Book | 1.86 X | ||||
Price To Sales | 1.71 X | ||||
Gross Profit | (42.7 M) | ||||
EBITDA | (43.77 M) | ||||
Net Income | (39.65 M) | ||||
Cash And Equivalents | 41.79 M | ||||
Cash Per Share | 8.59 X | ||||
Total Debt | 1.67 M | ||||
Debt To Equity | 0.07 % | ||||
Current Ratio | 4.82 X | ||||
Book Value Per Share | (0.40) X | ||||
Cash Flow From Operations | (43.61 M) | ||||
Short Ratio | 0.78 X | ||||
Earnings Per Share | (1.59) X | ||||
Price To Earnings To Growth | (0.29) X | ||||
Target Price | 5.0 | ||||
Beta | 0.25 | ||||
Market Capitalization | 341.07 K | ||||
Total Asset | 28.68 M | ||||
Retained Earnings | (512.62 M) | ||||
Working Capital | 19.23 M | ||||
Current Asset | 72.5 M | ||||
Current Liabilities | 3.83 M | ||||
Z Score | -29.14 | ||||
Net Asset | 28.68 M |
About Calithera Biosciences Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Calithera Biosciences's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Calithera Biosciences using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Calithera Biosciences based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis. You can also try the Balance Of Power module to check stock momentum by analyzing Balance Of Power indicator and other technical ratios.
Other Consideration for investing in Calithera Pink Sheet
If you are still planning to invest in Calithera Biosciences check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Calithera Biosciences' history and understand the potential risks before investing.
ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
Transaction History View history of all your transactions and understand their impact on performance | |
Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
Global Correlations Find global opportunities by holding instruments from different markets |